Clinical studies recruiting near Blacktown

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Blacktown Hospital /ID# 272182 · AbbVie · NCT06682988 An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/Phase 2 · Blacktown Hospital · Pathios Therapeutics Pty Ltd · NCT06634849 Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · Paratus Clinical Research Western Sydney · TRex Bio, Inc. · NCT06934252 Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Blacktown Hospital /ID# 265983 · AbbVie · NCT06896916 Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Blacktown Hospital · Impact Therapeutics, Inc. · NCT05269316 A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · Merck Sharp & Dohme LLC · NCT07247110 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979 ROADMAP Clinical Trial
Phase 4 · Blacktown Hospital · University of Newcastle, Australia · NCT06771050 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Blacktown Hospital · Daiichi Sankyo · NCT06330064 A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Soli
Phase 1 · Blacktown Cancer and Haematology Centre · BeOne Medicines · NCT07181681 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · Blacktown Hospital · BioNTech SE · NCT07070232 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injectio
Phase 1 · GSK Investigational Site · GlaxoSmithKline · NCT06431594 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Blacktown Cancer and Haematology Centre · BeOne Medicines · NCT07492641 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Paratus Clinical Western Sydney · Hoffmann-La Roche · NCT07351058 HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies
Phase 1/Phase 2 · Blacktown Hospital · Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · NCT06649708 STarting incrEmental Prescription of Peritoneal Dialysis
NA · Blacktown · The University of Queensland · NCT06642597 Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Phase 3 · Monash University · NCT05072314 A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · CStone Pharmaceuticals · NCT06741644 An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Soli
Phase 1 · Blacktown Cancer and Haematology Centre · BeOne Medicines · NCT07222267 Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Phase 4 · Blacktown Hospital · Todd C. Lee MD MPH FIDSA · NCT06637332 Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · Blacktown Medical Oncology Research, Blacktown Hospital · Revolution Medicines, Inc. · NCT06881784 A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate,
Phase 1 · Blacktown Cancer and Haematology Centre · BeOne Medicines · NCT06625593 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Blacktown Hospital · Hoffmann-La Roche · NCT05894239 A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · Site 11 · Merus B.V. · NCT06525220 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · Blacktown Cancer and Haematology Centre · BeOne Medicines · NCT06943872 A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · NSW Health - Blacktown Hospital · Bayer · NCT06760819 BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Phase 1 · Blacktown Cancer and Haematology Centre · BeOne Medicines · NCT06120283 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · NSW Health - Blacktown Hospital · Bayer · NCT06452277 A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 · Blacktown Cancer and Haematology Centre · BeOne Medicines · NCT06803680

Look up another city

Look up another condition